Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3421 AL 3435

The effect of intraventricular trajectory on brain shift in deep brain stimulation

Kramer DR, Halpern CH, Danish SF, Jaggi JL, Baltuch GH.

Stereotact Funct Neurosurg. 2012;90(1):20-4. doi: 10.1159/000332056. Epub 2011 Dec 22.

Changing practice patterns of deep brain stimulation in Parkinson's disease and essential tremor in the USA

Pilitsis JG, Burrows A, Peters ML, Sargent J, Ng SC, Tseng JF.

Stereotact Funct Neurosurg. 2012;90(1):25-9. doi: 10.1159/000333834. Epub 2011 Dec 22.

Exercise and motor training in people with Parkinson's disease: a systematic review of participant characteristics, intervention delivery, retention rates, adherence, and adverse events in clinical trials

Allen NE, Sherrington C, Suriyarachchi GD, Paul SS, Song J, Canning CG.

Parkinsons Dis. 2012;2012:854328. doi: 10.1155/2012/854328. Epub 2011 Nov 16.

Differences in motor and cognitive function in patients with Parkinson's disease with and without orthostatic hypotension

Hohler AD, Zuzuárregui JR, Katz DI, Depiero TJ, Hehl CL, Leonard A, Allen V, Dentino J, Gardner M, Phenix H, Saint-Hilaire M, Ellis T.

Int J Neurosci. 2012 May;122(5):233-6. doi: 10.1080/00207454.2012.642038. Epub 2011 Dec 22.

Cognition and functional performance in daily activities before and after pontine and extrapontine myelinolysis: a case study

Arciero S, Kempf C, Bernard F, Gosselin N.

Neurocase. 2012;18(6):496-502. doi: 10.1080/13554794.2011.633528. Epub 2011 Dec 22.

Olfaction in Parkinson's disease and related disorders

Doty RL.

Neurobiol Dis. 2012 Jun;46(3):527-52. doi: 10.1016/j.nbd.2011.10.026. Epub 2011 Dec 20.

Clinical and pathological characteristics of LRRK2 G2019S patients with PD

Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN.

J Mol Neurosci. 2012 May;47(1):139-43. doi: 10.1007/s12031-011-9696-y. Epub 2011 Dec 23.

Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage

Munro Neville A, Parsons RW, Askmark H, Nyholm D.

Parkinsonism Relat Disord. 2012 Jun;18(5):686-7. doi: 10.1016/j.parkreldis.2011.11.026. Epub 2011 Dec 23.

Diversity, biogenesis and function of microbial amyloids

Blanco LP, Evans ML, Smith DR, Badtke MP, Chapman MR.

Trends Microbiol. 2012 Feb;20(2):66-73. doi: 10.1016/j.tim.2011.11.005. Epub 2011 Dec 23.

Co-ordination of cough and swallow in vivo and in silico

Pitts T, Morris K, Lindsey B, Davenport P, Poliacek I, Bolser D.

Exp Physiol. 2012 Apr;97(4):469-73. doi: 10.1113/expphysiol.2011.063362. Epub 2011 Dec 23.

Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways

Soreq L, Ben-Shaul Y, Israel Z, Bergman H, Soreq H.

Neurobiol Dis. 2012 Mar;45(3):1018-30. doi: 10.1016/j.nbd.2011.12.021. Epub 2011 Dec 16.

GWAS-linked GAK locus in Parkinson's disease in Han Chinese and meta-analysis

Li NN, Chang XL, Mao XY, Zhang JH, Zhao DM, Tan EK, Peng R.

Hum Genet. 2012 Jul;131(7):1089-93. doi: 10.1007/s00439-011-1133-3. Epub 2011 Dec 24.

Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Singhal NK, Srivastava G, Agrawal S, Jain SK, Singh MP.

Mol Neurobiol. 2012 Feb;45(1):186-99. doi: 10.1007/s12035-011-8225-x. Epub 2011 Dec 24.

Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse

Yadav S, Gupta SP, Srivastava G, Srivastava PK, Singh MP.

Neurochem Res. 2012 Apr;37(4):875-84. doi: 10.1007/s11064-011-0682-0. Epub 2011 Dec 27.

Parkin: much more than a simple ubiquitin ligase

Alves da Costa C, Checler F.

Neurodegener Dis. 2012;10(1-4):49-51. doi: 10.1159/000332803. Epub 2011 Dec 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias